Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Clinical trial NCT06661720 · RECRUITING

Trial details

NCT number: NCT06661720
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Renal Cell Carcinoma (RCC)Stage II Renal Pelvis Cancer AJCC v8 Stage III Renal Pelvis Cancer AJCC v8

Start date: 2025-03-14
Primary completion: 2037-11-01
Enrollment: 1040

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.